Hui Xing

2.8k total citations
54 papers, 1.2k citations indexed

About

Hui Xing is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hui Xing has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Hui Xing's work include Cell death mechanisms and regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer-related Molecular Pathways (7 papers). Hui Xing is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer-related Molecular Pathways (7 papers). Hui Xing collaborates with scholars based in China, United States and Canada. Hui Xing's co-authors include Ding Ma, Danhui Weng, Jianfeng Zhou, Xiaokui Yang, Shixuan Wang, Yunping Lu, Gang Xu, Jinting Zhou, Xiaomin Qin and Gang Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hui Xing

46 papers receiving 1.2k citations

Peers

Hui Xing

ONCOL

IMMUN

PFM

Ashish Juvekar United States

Linjie Zhao China

Kang Jin Jeong United States

Hyunho Yoon South Korea

Joan Lewis-Wambi United States

Xiao-Feng Le United States

Doris R. Siwak United States

Marion Curtis United States

Karolina Wojtowicz Poland

Ji Nie China

Ashish Juvekar United States

Hui Xing

804 ×1.0

316 ×0.8

468 ×1.4

ONCOL

184 ×1.5

IMMUN

77 ×0.7

PFM

Citations per year, relative to Hui Xing Hui Xing (= 1×) peers Ashish Juvekar

Countries citing papers authored by Hui Xing

Since Specialization

Citations

This map shows the geographic impact of Hui Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xing more than expected).

Fields of papers citing papers by Hui Xing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xing. The network helps show where Hui Xing may publish in the future.

Co-authorship network of co-authors of Hui Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Xing. A scholar is included among the top collaborators of Hui Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Xing. Hui Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Mingyu, Pei Dong, Zheng Li, et al.. (2025). Multi-assistant methods improve stromal tumor-infiltrating lymphocytes (sTILs) assessment in breast cancer: results of multi-institutional ring studies. ESMO Open. 10(5). 105095–105095.

Xing, Hui, et al.. (2025). Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review. Reviews in the Neurosciences. 36(5). 545–576. 1 indexed citations

Luo, Juan, Jian Yang, Shanshan Li, et al.. (2025). Tumor-resident microbiota in gynecologic malignancies: Molecular mechanisms, clinical correlations, and translational potential. iScience. 28(11). 113729–113729.

Wang, Yanjun, Hui Xing, Yingying Zhang, et al.. (2025). A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis. Neuropsychiatric Disease and Treatment. Volume 21. 525–538.

Dong, Lemeng, et al.. (2025). A diffusion enhanced CRF and BiLSTM framework for accurate entity recognition. Scientific Reports. 15(1). 19670–19670.

Yu, Miao, Hui Xing, Hong Yin, et al.. (2024). Development and validation of a nomogram to predict the risk of adjacent segment disease after transforaminal lumbar interbody fusion in patients with lumbar degenerative diseases. Journal of Orthopaedic Surgery and Research. 19(1). 680–680. 1 indexed citations

Jiang, Yang, Mei Yang, Min Zhou, et al.. (2022). lncRNA SNHG15 Induced by SOX12 Promotes the Tumorigenic Properties and Chemoresistance in Cervical Cancer via the miR‐4735‐3p/HIF1a Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 8548461–8548461. 6 indexed citations

Liu, Qiong, Ying Zhao, Hui Xing, et al.. (2018). The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells. Gene. 689. 124–130. 20 indexed citations

Mao, Xiaogang, Xiaomin Qin, Lin Li, et al.. (2018). A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma. Gynecologic Oncology. 149(1). 181–187. 60 indexed citations

10.

Xu, Fan, Yanfang Li, Liangsheng Fan, et al.. (2018). Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage. Journal of Cancer. 9(9). 1660–1666. 28 indexed citations

11.

Li, Qinggang, Hui Xing, Dan Liu, & Hui Li. (2015). Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma. World Journal of Surgical Oncology. 13(1). 294–294. 17 indexed citations

12.

Zhang, Juan, et al.. (2015). Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells. Molecular and Cellular Biochemistry. 411(1-2). 331–340. 52 indexed citations

13.

Gao, Hui, Jie Meng, Hui Xing, et al.. (2014). Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women. Human Reproduction. 29(5). 1058–1066. 10 indexed citations

14.

Peng, Jing, et al.. (2010). Ozone injection for the treatment of lumbar disc herniation: a therapeutic analysis of 104 cases. Journal of interventional radiology. 19(2). 114–116. 1 indexed citations

15.

Weng, Danhui, Xiaohong Song, Hui Xing, et al.. (2008). Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells. Cancer Letters. 273(2). 257–265. 40 indexed citations

16.

Xing, Hui, Xiaobing Han, Xiaoyan Shi, et al.. (2008). Apoptosis of HeLa cells induced by cisplatin and its mechanism. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(2). 197–199. 21 indexed citations

17.

Xing, Hui, Yang Cao, Danhui Weng, et al.. (2007). Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel-induced apoptosis via inhibition of the p38 pathway. APOPTOSIS. 13(2). 213–223. 25 indexed citations

18.

Xing, Hui, Shixuan Wang, Ke‐Qin Hu, et al.. (2005). Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy. Journal of Cancer Research and Clinical Oncology. 131(8). 511–519. 38 indexed citations

19.

Li, Junpeng, Jianfeng Zhou, Shaogang Wang, et al.. (2005). Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model. Cancer Gene Therapy. 13(3). 266–272. 34 indexed citations

20.

Yang, Xiaokui, Hui Xing, Qinglei Gao, et al.. (2005). Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells. Gynecologic Oncology. 97(2). 413–421. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact